View in EDS

From algorithms to insights: The role of medical writers in AI-enhanced real-world evidence.

Saved in:
Bibliographic Details
Title: From algorithms to insights: The role of medical writers in AI-enhanced real-world evidence.
Authors: Jeyapal, Gomathi Priya, Reddy, Prarthana Vigneshwari, Satav, Vrushabh Baburao, Machiraju, Pattabhi
Source: Medical Writing; Sep2025, Vol. 34 Issue 3, p64-69, 6p
Subject Terms: ARTIFICIAL intelligence, MACHINE learning, MEDICAL writing, EMPIRICAL research, AT-risk people, PREDICTION models, CLINICAL decision support systems
Abstract: Real-world evidence (RWE) complements randomised controlled trials (RCTs) by assessing treatment effectiveness in diverse populations. Integrating artificial intelligence (AI) and machine learning (ML) enhances RWE by enabling predictive modelling, risk stratification, and clinical decision support. ML techniques like supervised or unsuper - vised learning, logistic regression, decision trees, random forests, and XGBoost can help optimise regulatory decision-making and patient care. This paper explores how the AI/ML models help identify high-risk patients, predict disease progression, and assess healthcare burden. The medical writer’s role in structuring findings into clinically meaningful insights is essential for bridging the gap between data science and clinical application. As AI advances, skilled medical writers will ensure transparency, ethical compliance, and effective communication of AI-driven RWE findings. [ABSTRACT FROM AUTHOR]
Copyright of Medical Writing is the property of European Medical Writers Association (EMWA) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Biomedical Index
Description
Abstract:Real-world evidence (RWE) complements randomised controlled trials (RCTs) by assessing treatment effectiveness in diverse populations. Integrating artificial intelligence (AI) and machine learning (ML) enhances RWE by enabling predictive modelling, risk stratification, and clinical decision support. ML techniques like supervised or unsuper - vised learning, logistic regression, decision trees, random forests, and XGBoost can help optimise regulatory decision-making and patient care. This paper explores how the AI/ML models help identify high-risk patients, predict disease progression, and assess healthcare burden. The medical writer’s role in structuring findings into clinically meaningful insights is essential for bridging the gap between data science and clinical application. As AI advances, skilled medical writers will ensure transparency, ethical compliance, and effective communication of AI-driven RWE findings. [ABSTRACT FROM AUTHOR]
ISSN:20474806
DOI:10.56012/vysp1464